Press release
Electrophysiology Market is Driven by Limited Effectiveness of Anti-Arrhythmic Medications
Atrial and ventricular fibrillation, tachycardia, and other diseases that have an impact on the heart are mostly diagnosed and treated with electrophysiology equipment. Healthcare professionals use a variety of tools based on the electrophysiological technique to identify and treat various disorders, including ablation and diagnostic catheters, mapping systems, etc.
Download Free Sample of Report - https://www.globalinsightservices.com/request-sample/GIS10275
Market Trends and Drivers
The increasing incidence of target diseases and procedures is boosting the growth of the market. According to the WHO, CVD is the largest global cause of death. Age, race, and family history are significant factors influencing the increased prevalence of CVD and strokes. Other risk factors include using tobacco, having high blood pressure (hypertension), having high cholesterol, being obese, being physically inactive, having diabetes, eating unhealthily, and drinking alcohol. The prevalence of CVD is on the rise in part due to conditions like hypertension, diabetes, dyslipidemia, and obesity. By 2030, the American Heart Association projects that 41.4% of US individuals will have hypertension (an increase of 8.4 percent from 2012). Additionally, according to the organization, the cost of CVD will increase from USD 863 billion in 2010 to USD 1,044 billion by 2030. Globally, 17.9 million people passed away from CVD in 2016. According to projections, this number will reach 23.6 million by 2030.
Read more about Electrophysiology Market here: https://www.globalinsightservices.com/reports/electrophysiology-market/
The American Heart Association (AHA) claims that catheter-based ablation techniques have a 90% success rate, and minimal risk of complications, and allow patients to return to their regular activities in a few days. Leading businesses are investing more in the creation of novel cardiac ablation devices to increase success rates and decrease problems during procedures, including Biosense Webster, Medtronic, and Boston Scientific Corporation.
The limited effectiveness of anti-arrhythmic medications in the management of arterial filtration is another factor boosting catheter ablation demand. A study titled Radiofrequency Ablation vs. Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT 2) presented its findings in Massachusetts (US) in May 2012 at the Heart Rhythm Society meeting, concluding that ablation of AF, when used as a first-line method, was superior to medications that control rhythm.
Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS10275
Market Segments
By Product Type
Electrophysiology Ablation Catheters
Electrophysiology Laboratory Devices
Electrophysiology Diagnostic Catheters
Electrophysiology Access Devices
Others
By Indication Type
Atrial Fibrillation
Atrial Flutter
Atrioventricular Nodal Reentry Tachycardia
Wolf-Parkinson-White Syndrome
Others
By End Users
Hospitals & Cardiac Centers
Ambulatory Surgery Centers
By Region
North America
The U.S.
Canada
Mexico
Europe
UK
Germany
France
Spain
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Rest of World
Latin America
Middle East
Africa
Purchase This Market Research Report - https://www.globalinsightservices.com/checkout/single_user/GIS10275
Major Players in the Global Electrophysiology Market
The key players studied in the global electrophysiology market are Abbott (US), Medtronic (Ireland), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthcare GmbH (Germany), Stereotaxis, Inc. (US), Merit Medical Systems (US), Atricure Inc. (US), APN Health, LLC (US), Osypka Medical (Germany), Japan LifeLine Co., Ltd. (Japan), Johnson & Johnson (US), Biotronik (Germany), MicroPort Scientific Corporation (China), Acutus Medical, Inc. (US), Lepu Medical Technology (Beijing), CathRx Ltd. (Australia), Cook Medical (US), CathVision ApS (Denmark), TZ Medical (US), Teleflex Incorporated (US), Imricor (US), CardioFocus (US), Schwarzer Cardiotek GmbH (Germany), Kardium (Canada), EP Solutions SA (Switzerland), BioSig Technologies Inc. (BSGM) (US), Coremap (US), and EPMap System GmbH (Germany).
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
Groundbreaking research and market player-centric solutions for the upcoming decade according to the present market scenario
New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with the highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Electrophysiology Market is Driven by Limited Effectiveness of Anti-Arrhythmic Medications here
News-ID: 3099195 • Views: …
More Releases from Global Insight Services
Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Ke …
Market Overview
GLP-1 Agonist Market is rapidly evolving as the demand for advanced diabetes and obesity treatments continues to rise globally. These drugs, known as glucagon-like peptide-1 receptor agonists, help improve insulin secretion, reduce glucagon levels, and enhance satiety-making them a powerful solution for type 2 diabetes and weight management. With diabetes and obesity reaching unprecedented levels, the GLP-1 Agonist Market stands at the forefront of therapeutic innovation. Growing patient awareness,…
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2 …
Market Overview
Financial Risk Management Software Market is evolving rapidly as financial institutions and enterprises navigate increasingly complex global uncertainties. With tightening regulations and growing exposure to market volatility, organizations are turning toward advanced digital solutions that help identify, assess, and mitigate financial risks in real time. The Financial Risk Management Software Market integrates AI, machine learning, predictive analytics, and cloud technologies to enhance credit, liquidity, operational, and market risk insights.…
Esg Risk Management Market To Rise From $268.8 MN To $1,032.2 MN By 2034 At 14.4 …
Market Overview
ESG Risk Management Market is gaining significant momentum as businesses increasingly prioritize sustainability and ethical governance in their operations. Valued at $268.8 million in 2024, the market is projected to surge to $1,032.2 million by 2034, growing at a CAGR of 14.4%. The ESG Risk Management Market encompasses technologies and services designed to identify, monitor, and mitigate environmental, social, and governance risks, ensuring businesses operate responsibly while complying with…
Enterprise Firewall Market To Grow From $15 BN (2024) To $40.3 BN (2034) At 10.4 …
Market Overview
Enterprise Firewall Market is witnessing substantial growth as organizations worldwide prioritize safeguarding their digital infrastructure from sophisticated cyber threats. Valued at $15 billion in 2024, the market is projected to reach $40.3 billion by 2034, expanding at a CAGR of 10.4%. The Enterprise Firewall Market encompasses solutions designed to secure enterprise networks by monitoring, filtering, and blocking unauthorized access while ensuring uninterrupted business operations. With the surge in cyberattacks,…
More Releases for Electrophysiology
Electrophysiology Market worth $15.1 billion by 2028
Electrophysiology Market in terms of revenue was estimated to be worth $8.2 billion in 2023 and is poised to reach $15.1 billion by 2028, growing at a CAGR of 13.0% from 2023 to 2028 according to a new report by MarketsandMarkets™. Many factors, such as technological advancements, funding and reimbursement, strong healthcare funding, active research funding, a clear regulatory framework, growing minimally invasive procedure adoption, and the presence of key…
Electrophysiology Devices Market - Empowering Cardiac Care: Innovations in Elect …
Newark, New Castle, USA: The "Electrophysiology Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Electrophysiology Devices Market: https://www.growthplusreports.com/report/electrophysiology-devices-market/8036
This latest report researches the industry structure, sales, revenue,…
Electrophysiology Market Business Strategies, and Regional Outlook
The global electrophysiology market is on the path to generating $17,482.7 million by 2030, compared to $7,076.1 million in 2021, advancing at a compound annual growth rate of 10.6% between 2021 and 2030. The growing count of cardiac ablation procedures, rising reforms for healthcare infrastructure growth, increasing demand for ablation and diagnostic catheters, and technology advancements are some major aspects driving the growth of the market.
Furthermore, in 2021, laboratory devices…
Electrophysiology (EP) Device Market 2022 | Detailed Report
The Electrophysiology (EP) Device market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Electrophysiology (EP) Device report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The Electrophysiology (EP) Device research report also provides insights of different…
Electrophysiology (EP) Device Market 2021 | Detailed Report
The Electrophysiology (EP) Device research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Electrophysiology (EP) Device research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force.
Get Free Sample PDF…
Global Electrophysiology Market Report Forecast to 2027
The study aids in the evaluation of aberrant heartbeats and the examination of electrical impulses in the heart. The ability to target the regions of the heart that cause atrial fibrillation has improved because of substantial advancements in EP technology. Other cardiac arrhythmias, such as atrial flutter, Wolff-Parkinson-White Syndrome (WPW), atrioventricular nodal reentry tachycardia (AVNRT), and others, have benefited from the advancements in technology.
Global Electrophysiology market was valued at $5.69…
